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Public policy must confront emergencies that evolve in real time and in uncertain directions 
[1-6], yet little is known about the nature of policy response. Here we take the coronavirus 
pandemic as a global and extraordinarily consequential case [7-12], and study the global 
policy response by analyzing a novel dataset recording policy documents published by 
government agencies, think tanks, and intergovernmental organizations (IGOs) across 114 
countries (37,725 policy documents from January 2nd through May 26th 2020). Our analyses 
reveal four primary findings. (1) Global policy attention to COVID-19 follows a remarkably 
similar trajectory as the total confirmed cases of COVID-19, yet with evolving policy focus 
from public health to broader social issues. (2) The COVID-19 policy frontier 
disproportionately draws on the latest, peer-reviewed, and high-impact scientific insights. 
Moreover, policy documents that cite science appear especially impactful within the policy 
domain. (3) The global policy frontier is primarily interconnected through IGOs, such as the 
World Health Organization, which produce policy documents that are central to the COVID-
19 policy network and draw especially strongly on scientific literature. Removing IGOs’ 
contributions fundamentally alters the global policy landscape, with the policy citation 
network among government agencies increasingly fragmented into many isolated clusters. 
(4) Countries exhibit highly heterogeneous policy attention to COVID-19.  Most strikingly, 
a country’s early policy attention to COVID-19 shows a surprising degree of predictability 
for the country’s subsequent deaths. Overall, these results uncover fundamental patterns of 
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policy interactions and, given the consequential nature of emergent threats and the paucity 
of quantitative approaches to understand them, open up novel dimensions for assessing and 
effectively coordinating global and local responses to COVID-19 and beyond. 
 
The global policy response to the COVID-19 pandemic 
Human society is often challenged by emergencies, from natural disasters [1-3] and pandemics [7, 
8, 13, 14] to human conflicts [15, 16] and other emergent crises [3, 17, 18]. Despite the 
consequential nature of public response [6-12], governments often struggle to manage these 
emergent problems, potentially due to various reasons ranging from the inherent difficulties in 
altering rules and allocating attention and resources [19, 20] to uncertainties about the evolving 
nature of the problems [19-21].The COVID-19 pandemic provides a high-stakes case for 
examining the nature of policy response [5-12, 20]. Indeed, the coronavirus pandemic is not only 
a public health crisis but also creates enormous challenges to social, economic, and political 
systems around the world [19, 20, 22]. At the same time, evolving knowledge about the nature of 
the disease [23, 24], as well as evolving knowledge about containment policies and social 
implications [5, 7-11, 19, 20, 22], presents a dynamic and uncertain policy environment. 
 
To quantify the global policy response to the COVID-19 pandemic, we analyze a novel dataset of 
policy documents (37,725 documents published from January 2nd to May 26th, 2020). The dataset 
categorizes the source, topics, publication date of each policy document, and further includes each 
document’s cited references. The institutions include government agencies, think tanks, and 
intergovernmental organizations (IGOs). The coverage is worldwide, with policy documents from 
114 countries, and includes all major economies and large population centers, with a notable 
exception of mainland China, overall covering ~66.3% of the world population, ~79.3% of total 
Gross Domestic Product (GDP), and ~95.6% of confirmed deaths worldwide due to COVID-19 
(as of May 30th, see Fig. S1 and SI S1.1 for further description). Within this corpus, we identify 
COVID-19 related policy documents through keyword filtering (7,730 documents in total, see SI 
S1.1), allowing us to compare COVID-19 policy documents with all other policy documents 
published in 2020. For each policy document, we further analyze all the references cited therein, 
allowing us to link policy documents to scientific papers and other policy documents they 
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reference. These linkages can inform how different institutions interact in policy making and also 
illuminate the nature of the scientific knowledge upon which these policies draw.  
 
Overall, the total number of policy documents recorded in our database grows roughly linearly 
with time, averaging approximately 280 new policy documents per day (Fig. 1A). By contrast, the 
number of COVID-19 related policy documents features highly non-linear growth, approximated 
by an exponential pattern (Fig. 1B and inset), showing rapid shifts in global policy attention over 
the past few months. To understand how policy attention tracks the coronavirus outbreak, we 
measure the share of policy attention to COVID-19 by calculating the proportion of COVID-19 
related policy documents among all policy documents published on a given day. We then compare 
this share with how the pandemic unfolded globally, as traced by the Johns Hopkins COVID-19 
tracking map [23]. We find that the share of COVID-19 policy attention shows a remarkably 
similar trajectory as the total confirmed cases of COVID-19 over time (Fig. 1C, red vs blue). We 
observe the same pattern when using total confirmed deaths (Fig. S2). Together, these results show 
that the share of policy attention to COVID-19 closely corresponds to the global unfolding of the 
pandemic (see SI S3.1 for more detail). 
 
To inform how the COVID-19 policy attention may reflect policy-making institutions’ priorities, 
we further examine the content of the COVID-19 related policy documents, breaking them down 
by field (Fig. 1D) and topic (Fig. 1E). For both analyses, we observed clear shifts in policy 
attention related to the pandemic, with policy priorities shifting from issues in public health to 
economy and society. Indeed, we first classify COVID-19 related policy documents by field, 
grouping them into three major field categories (“science & health”, “economy & labour”, and 
“society & others”, see SI S2.1 for more detail). Plotting the share of COVID-19 policy documents 
across these field categories (Fig. 1D), we find that in the early stage of the outbreak (January and 
February 2020), about 90% of COVID-19 policies belong to the health and science category, 
showing a clear, initial focus on public health issues. The policy priorities show a visible shift, 
however, since early March 2020, with a notable rise in policy attention to issues around the 
economy and society, suggesting a growing policy balance between health and socio-economic 
implications of the pandemic (see Fig. S3B for results at the individual field level). 
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We further break down these policy documents at the narrower topic level, plotting dynamics 
related to COVID-19 for the top 10 topics (Fig. 1E). We find again an initial focus on health-
related topics (in blue), followed by a clear increase over time in the share of topics related to 
economy and society (in red). Indeed, Fig. 1F-G respectively show the word cloud of all topics 
pre- and post-WHO’s pandemic declaration, which illustrates a stark difference in policy priorities 
across the two periods, shifting sharply from public health to socioeconomic issues (see Fig. S3A 
for topic changes by month). Furthermore, the shifts documented in Figs. 1D-G are observed in 
COVID-19 policy documents only, as we repeated all our analyses for other policy documents 
published in the same period, finding that their shares by field or topic are relatively stable over 
time (Fig. S4). 
The role of science in the COVID-19 policy response 
Overall, Fig. 1 demonstrates a rapidly evolving global policy frontier that closely corresponds to 
the evolution of the pandemic. Yet at the same time the scientific research related to COVID-19 
also evolves rapidly, as exemplified by the strong response from the global research enterprise [5, 
20]. Indeed, as of May 30th 2020, over 40,000 papers on coronavirus research have been published 
in 2020, with preprint servers playing an outsize role in disseminating the latest science [22, 25]. 
The parallel advancement of the policy and scientific frontier in response to the pandemic raises a 
crucial question: is our policy understanding of COVID-19 closely linked with scientific 
understanding, or largely separated from the ivory tower? To answer this question, here we trace 
all scientific papers cited by policy documents in our corpus and match them to large-scale 
publication and citation databases (SI S1.2), offering a unique opportunity to quantify the role of 
science in the global policy response to COVID-19. 
 
We find that COVID-19 policy documents rapidly evolve with the scientific frontier. First, Fig. 
2A shows that the probability for these policy documents to cite at least one scientific paper 
fluctuates until WHO’s pandemic declaration, and features a steady increase afterward. Fig. 2B 
plots the age distribution of scientific evidence referenced by COVID-19 policy documents, 
showing that COVID-19 policies are disproportionately centered on the latest scientific frontier. 
Indeed, out of all scientific references drawn upon by COVID-19 policy documents, 19.9% of the 
scientific papers were published in 2020. This rate of utilizing the most recent scientific knowledge 
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is over ten times larger than seen for other policy documents. Not surprisingly, we find that the 
latest scientific evidence cited by COVID-19 policies is primarily related to research on 
coronavirus (88.4%). However, as policy attention shifts gradually from health to economy over 
the course of the pandemic (Fig. 1D-E), we also observe a similar shift in the fields of science that 
COVID-19 policies cite (Fig. 2C), showing a clear shift from drawing primarily upon the 
biomedical literature to citing economics, society, and other fields of study (Figs. S3C).  
 
Together, these results suggest that despite the extremely recent development in COVID-19 related 
scientific research, new scientific work substantially finds its way into policy documents, 
prompting us to next examine the quality of scientific evidence that informs policy. To proceed, 
we separate COVID-19 related papers into two groups based on whether or not they are referenced 
by policy documents. We then measure each paper’s scientific impact, approximated by the 
number of citations the paper receives from other scientific papers. We find a dramatic impact 
difference between the two groups (Fig. 2D): papers referenced in policy documents garner on 
average 40 times higher citations than those not referenced in policy (average citations: 67.72 vs 
1.67). This result shows that the coronavirus research used by policymakers tends to align with 
what scientists themselves consider important.  
 
Figure 2E further breaks down the policy coverage of COVID-19 related research based on 
publication venues. We find that different venues differ widely in publication volume, with 
preprint servers such as medRxiv, bioRxiv, and SSRN publishing an order of magnitude more 
COVID-19 related papers than peer-reviewed journals. Yet, despite the large amount of papers 
posted on preprint servers, their impact in policy is rather limited, as these preprint servers show 
consistently fewer policy citations than average. By contrast, COVID-19 policies 
disproportionately reference peer-reviewed insights, drawing especially heavily on respected 
medical journals, both general (e.g., Lancet) and specialized (e.g., Clinical Infectious Diseases). 
Amid growing concerns over the quality and abundancy of coronavirus research posted on preprint 
servers [26], these results show that peer-reviewed journals appear to remain an important 
institution in supplying scientific evidence for policy making.   
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Overall, the COVID-19 policy frontier appears grounded in extremely recent, peer-reviewed 
scientific insights, and science directly drawn by this policy frontier is viewed as especially 
impactful within the scientific community itself. Our next set of analyses present the same pattern 
but on the other side of the policy-science interface, showing that policy documents that are 
grounded in the scientific frontier tend to gather substantially more use within the global policy 
network. Figure 2F separates COVID-19 policy documents by whether they cite any scientific 
reference or not, and compares the average number of citations from other policy documents. We 
find that COVID-19 policy documents that cite at least one scientific paper are associated with a 
significantly higher number of citations from other policies, more than doubling its policy use than 
those without scientific references. To test if the difference observed in Fig. 2F can be explained 
by other covariates, we further use a regression model (see Table S1 and SI S3.3 for more detail) 
to control for policy sources, the total number of scientific references, the date of policy documents, 
and self-citations, finding our conclusions remain the same (P < 0.001). Together, the results in 
Fig. 2 show that, despite the rapidly evolving nature of the pandemic, the policy and scientific 
frontier of COVID-19 are closely interlinked, with advances directly along the policy-science 
interface being notably more impactful within their own domains.  
The role of institutions in the COVID-19 policy response 
Figure 3 considers the varied role of policy-making institutions in the global policy frontier of 
COVID-19. Analyzing policy documents from three types of institutions (government agencies, 
think tanks, and IGOs), we find that overall IGOs produce the fewest number of documents (Fig. 
3A), yet the policy documents they produce tend to be most closely connected to the scientific 
frontier (Fig. 3B) and occupy a central position within the global policy network (Fig. 3C-E). We 
visualize the policy citation network among COVID-19 policy documents in Fig. 3E. Each node 
is a COVID-19 policy document with at least one citation linkage to other COVID-19 policy 
documents, and two nodes are connected if one policy cites the other. We color the nodes based 
on the institution that published the policy (IGOs in blue, think tanks in orange, and governments 
in green). A node’s size is proportional to the number of citations received within this policy 
network. We also add a node border (in black) for those that draw on scientific papers.  
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The networks convey three primary insights (Fig. 3C-E). First, although IGOs produced the fewest 
number of policy documents among the three types of institutions (Fig. 3A), blue nodes are the 
most visible within the network, indicating IGOs are disproportionately more likely to produce 
hubs within the policy network (Fig. 3F). Second, hubs in this policy network mostly have black 
borders, indicating that those that attracted more policy use are also directly grounded in science, 
consistent with Fig. 2F. Third, while the connectivity among policy documents is relatively sparse 
(2,994 linkages between 2,098 nodes, <kin> = <kout> = 1.43), a high fraction of policy documents 
coalesce into the same giant weakly connected component (GWCC, 70.3%), illustrating the 
connectedness within the global policy frontier.   
 
To quantify the relative locations of policy documents within the network, we use the k-core 
algorithm to calculate the coreness of each node (Fig. 3F inset, SI S3.2). A popular concept to 
measure the core-periphery structure of complex networks, k-core is a maximal subgraph of the 
original network, all of which are connected to at least k other nodes in the group [27]. Figure 3F 
inset compares the distribution of coreness for policy documents produced by the three institutions, 
showing policy documents produced by IGOs systematically occupy central positions within the 
network, characterized by a high k-core score. More importantly, these IGO documents appear 
critical for the global connectivity of this policy network. In Fig. 3G we randomly remove a fixed 
number of nodes from certain types and measure the remaining GWCC size [28, 29], finding IGO 
documents carry disproportionate importance in connecting the network. Indeed, as Fig. 3E shows, 
removing IGOs’ policy documents drastically alters the structure of the policy network. While 
IGOs only account for 31.0% of the nodes (Fig. 3C), removing them shrinks the GWCC from 70.3% 
to 18.0 % (Fig. 3DG). Contrasting IGOs with other institutions, we find that the effects of removing 
policy documents by think tanks or government agencies are not nearly as significant (Fig. 3D-
EG). Lastly, the fraction of the GWCC decreases to merely 5.77% if we further remove all think 
tank policy documents, keeping only those by government agencies (Fig. 3E), highlighting that 
policies by individual countries rarely connect directly across geopolitical boundaries.  
The effectiveness of local COVID-19 policy responses 
Taken together, Fig. 3 shows that the overall connectedness in the COVID-19 policy frontier is 
mainly mediated by IGOs, the absence of which alters the global policy landscape. And among 
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IGOs, the WHO plays a dominant role across all 55 organizations recorded in our data (Fig. 3H). 
While these results highlight the critical role of IGOs and especially the WHO in policy responses 
to COVID-19 [30, 31], they also suggest that the apparent connectivity in the global COVID-19 
policy network hides a high degree of isolation at the individual governmental level. Indeed, if we 
only consider policy responses by government agencies, individual countries are fragmented into 
small isolated clusters, as their COVID-19 policies primarily interact within their geopolitical 
boundaries. This suggests that individual countries may differ in their policy response to COVID-
19 [6, 32], prompting us to examine whether country-level variations in COVID-19 policy 
attention may predict country-specific realities of the pandemic.  
 
Therefore, in our final analyses, we consider the COVID-19 policy response at the individual 
country level, and explore its correlation with the country’s effectiveness in containing the 
pandemic (Fig. 4). For each country in our database, we mark the calendar date when three 
COVID-19 deaths were first recorded within the same day [33]. We then measure the country’s 
total deaths from COVID-19 over the following 30 days, which approximates the country’s 
effectiveness in containing the disease. We further calculate the share of policy attention to 
COVID-19 in that country during the prior 30 days, i.e., in the 30 days before three daily deaths 
were first recorded in that country. Plotting the results in Fig. 4A, we find a strong negative 
correlation (n = 59, P < 0.00001), showing that countries with a greater share of policy documents 
addressing COVID-19 experienced substantially fewer subsequent deaths. 
 
Several additional analyses help further assess this result. Specifically, countries with larger 
populations may naturally experience greater deaths. Countries with greater per-capita income 
may also be more susceptible (e.g., through higher influxes of international travel). Finally, 
countries that experienced later onset of the outbreak may have more time to prepare and learn 
from others. Table S2 considers various regression models to control for these additional features. 
We find robust evidence that greater population predicts greater death and that later onset of the 
disease is associated with less ensuing death, which is consistent with global learning about how 
to handle the pandemic. At the same time, the explanatory power of a country’s early policy 
attention remains robust. Figure 4B shows the ongoing predictive role of a country’s prior policy 
attention, net of other controls (P = 0.043). Figure 4C shows the collective power of prior policy 
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attention and the other controls in predicting subsequent deaths, demonstrating the substantial 
predictive capacity of this simple model. 
 
We further test the robustness of these findings across several additional dimensions. We restrict 
the analysis to countries with higher volumes of policy documents recorded in our database (Tables 
S3-S4), examine different daily death thresholds to mark the onset of the disease for each country 
(Fig. S7) and consider alternative functional forms (Tables S2-S4). We also adopt alternative data 
sources for the COVID-19 tracking data, as provided by the European Centre for Disease 
Prevention and Control (Fig. S5D), alter the measures of a country’s effectiveness in containing 
the pandemic by calculating total confirmed cases instead of deaths (Fig. S5A), examine per-capita 
death rates for each country (Fig. S5B), and restrict the analysis to countries with a minimum 
number of COVID-19 policy documents (Fig. S6). The findings are broadly robust to these many 
alternatives. Finally, we use an alternative policy attention measure – the stringency index 
provided by the Oxford COVID-19 Government Response Tracker (OxCGRT) [6] – which is 
developed independently of the Overton policy document database we studied. This alternative 
source shows a similar relationship (Table S5), where greater policy stringency predicts fewer 
subsequent deaths, and further suggests the robustness of our result.  
 
Overall the results suggest a country’s early policy attention to COVID-19 predicts its containment 
of the outbreak. The patterns presented in Fig. 4 are correlations and do not identify causal 
mechanisms. Indeed, there are a large number of social, cultural, economic, and political factors 
that may influence a country’s response to COVID-19. Yet, despite these many potential 
influences and complex factors, a country’s early policy attention provides a simple yet powerful 
proxy that closely predicts a country’s effectiveness in containing the pandemic, offering a new 
dimension in measuring heterogeneous policy responses and predicting differences in outcomes. 
Concluding remarks 
While the data used in this paper represents among the largest collection of policy documents 
worldwide, there are limitations of the data that should be considered when interpreting the results 
(SI S1.4, S3.4-S3.10). First, policy documents from mainland China, where the COVID-19 
originated, are notably missing from the data. Second, many policy documents are written in the 
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native language of a country, requiring an additional machine translation step to integrate the 
corpus, which was performed at the data source. It is important to keep this language effect in 
mind, which may generate differential data quality for non-English speaking countries. It is worth 
noting that potential sampling biases in our data are likely to be conservative. Indeed, we repeated 
our analyses in Fig. 4 for English-speaking countries only (SI S3.7), finding that the relationship 
further strengthens (Fig. S5C). Lastly, the data focus on policy responses at the country level, while 
across regions within each country there can be important local differences in response [12, 34, 
35], which are not captured by our data.  
 
The data and methodologies presented in our paper are not limited to analyzing COVID-19 policy, 
highlighting several fruitful future avenues to quantitatively investigate policies, including their 
rich connections to other policies as well as to the scientific literature. Future work may extend 
our analyses to other large-scale emergencies or historical events. Equally fruitful is the potential 
to quantitatively analyze patterns of policy interactions under normal circumstances, which may 
uncover new signals for relevant social economic indicators. Lastly, the linkage between policy 
documents and scientific papers opens up new possibilities for understanding how policy and 
science interact, which would not only broaden our definition of scientific impact [36, 37], but 
also deepen our understanding of the role of science in human society. Taken together, these results 
unveil core patterns in the global policy landscape and its dynamics in the COVID-19 pandemic, 
opening new windows in our quantitative understanding and predictions of policy responses and 
the enormously important outcomes they govern.  
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Figures captions 
Figure 1. Policy responses to the COVID-19 pandemic. (A) Linear growth in the cumulative 
number of all policy documents published since 2020. (B) Non-linear growth in the cumulative 
number of COVID-19 policy documents. Timeline shows major events including lockdowns and 
total confirmed cases of the COVID-19 infection. (Inset) Same as the main panel but in log-linear 
scale. Red dashed line shows an exponential function as a guide to the eye. (C) Policy documents 
mirror the case dynamics, showing a synchrony between the share of COVID-19 policy documents 
among all policy documents and the number of total confirmed cases. (D) The share of COVID-
19 policy documents across three broad subject categories (21-day moving average). (E) The share 
of COVID-19 policy documents across topics (21-day moving average). Only the top 10 topics 
are shown (SI S2.1). Policy documents are counted multiple times by topics they cover. Color blue 
and red marks health- and economy-related topics, respectively. (F) Word clouds of all topics in 
COVID-19 policy documents published before (F) and after (G) the WHO pandemic declaration 
(March 11, 2020). Throughout the figures, the black dashed line marks the date of the WHO 
pandemic declaration.  
Figure 2. The use of science in COVID-19 policy documents. (A) Probability of citing scientific 
references for COVID-19 policy documents published in 2020 (21-day moving average). The 
dashed red line represents the average rate of citing science by Non-COVID-19 policy documents 
in 2020. (B) Distribution of publication years of scientific papers cited by COVID-19 and other 
policy documents. There is an unusual spike in citing papers published in 2020, indicating that 
COVID-19 policies draw heavily on recent scientific evidence. (C) Research fields of all scientific 
papers cited by COVID-19 policy documents across three broad field categories (21-day moving 
average). There is a clear shift from the initial focus on health and science to economy and society, 
which is consistent with the results in Fig. 1D. (D) Among COVID-related scientific papers, those 
cited by COVID-19 policy documents on average have greater citation impact within science. (E) 
For different journals and preprint servers, the number of COVID-19 papers (x-axis) and the 
average number of citations from COVID-19 policy documents (y-axis) in 2020. While preprint 
servers published a large number of COVID-19 papers, peer-reviewed journal papers received 
substantially more COVID-19 policy citations than preprints. (F) COVID-19 policy documents 
that cite scientific papers are much more likely to be cited by other COVID-19 policy documents. 
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Figure 3. The complex network behind COVID-19 policy documents. (A) Number of COVID-
19 policy documents published by governments, think tanks, and intergovernmental organizations 
(IGOs). (B) Probability of citing science for these different institutions. (C) Network visualization 
for the COVID-19 policy document citation network. Each node corresponds to a COVID-19 
policy document, colored by the institution type to which it belongs, A link between documents is 
colored by a mixture between colors of the source and target nodes. The size of each node is 
proportional to the number of citations it receives from other COVID-19 policy documents. (D) 
The same as (C) but removing IGOs. (E) The same as (C) but only keeping policy documents 
published by government agencies (removing both IGOs and think tanks). In the absence of IGO 
policy documents, connectivity declines especially sharply and government policy documents 
become isolated in the citation network. (F) The citation distribution (in-degree) within the policy 
network by institutions. (Inset) The coreness score distribution (k-core). As the coreness measure 
is commonly used in undirected networks, here we treat the network as undirected when 
calculating the k-core score. (G) The weakly giant connected component size as we randomly 
remove policy documents from IGOs/think tanks/government agencies. Error bars represent 
standard errors. (H) Top 5 IGOs in the network, ranked by the total number of policy citations in 
the network. We also calculate their number of nodes (policy documents in the network).  
Figure 4. Policy attention and the effectiveness of local COVID-19 response. (A) The 
significant negative correlation between the share of COVID-19 policy documents published in 
the 30 days before 3 daily deaths were first recorded (i.e., the prior 30 days), and the total deaths 
in the 30 days after 3 daily deaths were first recorded (i.e., the following 30 days). To accommodate 
the logarithmic scale, the share of COVID-19 policy documents is represented as 
(#COVID+1)/(#ALL+1), where #COVID and #ALL are the number of COVID-19 and all policy 
documents, respectively. The gray line is a linear fit to the data. (B) The residual plot shows that a 
significant negative correlation remains between COVID-19 policy share in the prior 30 days (x-
axis) and the residual of the regression (y-axis) after controlling for GDP per capita, population 
size, the calendar day of 3 daily deaths were first recorded, and a dummy variable capturing 
whether a country has no COVID-19 policy documents in the prior 30 days (SI S2.4). (C) The 
predictive power of the share of COVID-19 policy attention together with all other control 
variables in (B) (x-axis, the composite index) for total deaths in the following 30 days (y-axis). 
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Figure 1. Policy responses to the COVID-19 pandemic.  
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Figure 2. The use of science in COVID-19 policy documents. 
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Figure 3. The complex network behind COVID-19 policy documents. 
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Figure 4. Policy attention and the effectiveness of local COVID-19 response. 
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S1 Data Description  
S1.1 Overton data overview 
To understand the global policy response to the COVID-19 pandemic, we leverage a novel dataset 
provided by Overton (www.overton.io). Overton data captures among the world’s largest 
collection of policy documents [1]. Policy documents are broadly defined as documents written 
primarily for or by policymakers, and include documents from government agencies, think tanks 
as well as intergovernmental organizations (IGOs) [1]. The data is updated weekly, allowing us to 
trace how policy responses evolve in nearly real time. In 2020, the Overton database has captured 
over 43,000 policy documents from 114 countries, collecting documents from more than 750 
different sources worldwide.   
 
In this paper, we use the full set of policy documents published from January 1st 2020 to May 26th 
2020. We use an API to obtain policy documents from each policy source separately. For each 
document, we have information on its title, original URL, publication date, document type, policy 
source, and subject classification codes. 
 
To identify COVID-19 related policy documents, we leverage Overton’s technical capabilities 
which combine translation of policy document into English, with keyword-based search for a list 
of COVID-19 related keywords across multiple languages [2]. Note that the list of keywords also 
relies on pre-translation to English by Overton (see S1.4 below). While the data cover a large 
number of countries, there are two notable exceptions in our analyses. First is the Netherlands. 
One empirical limitation is that our access to the API only allows for at most 2,000 results per 
query, and there is one country that has exceeded this limit. Indeed, the Government of the 
Netherlands (Rijksoverheid) has published over 4,000 documents in 2020, making it impossible 
to collect the full set of its policy documents. We therefore exclude Netherlands from our analysis 
to avoid potential bias. Second is mainland China. Although COVID-19 originated from Wuhan, 
China, policy documents from mainland China are missing in the Overton database for 2020.  
Personal correspondence with the Overton team has not pinpointed the reason for this missing data, 
but it may have to do with web crawling issues on Chinese government websites [3].  
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We focus on policy documents published by (1) government agencies and think tanks in country 
members of the United Nations, and (2) intergovernmental organizations (defined by “IGO” and 
“EU” source labels in the Overton data). For the temporal coverage, we froze our data on May 
26th, 2020. We noticed that there is an unusual number of documents published on January 1st 
2020 (1,036 documents, about 4 times of a normal day), possibly due to default classification to 
this date. We further excluded these documents from our analyses to avoid including policy 
documents that have inaccurate publication dates. Lastly, since our main focus is on policy 
documents, we follow Overton’s suggestion [3] and further filter on the document type by using 
only “publications” (95% of the total documents), removing other types such as “working papers”, 
“transcripts”, “blog posts”, and “clinical guides”.  
 
In total, we analyzed 7,730 COVID-19 documents out of 37,725 documents published across 114 
countries (including 402 think tanks), 55 IGOs (including 4 in EU). 
S1.2 Dimensions publication data 
We further link the scientific references cited within the policy documents to a database of 
scientific publications. For this database, we use Dimensions [4], a recent data product by Digital 
Science. Each scientific reference from Overton has a unique DOI (Digital Object Identifier), one 
of the most commonly used identifiers for scientific publications. We retrieve papers from 
Dimensions API using the DOI information. We find that the vast majority of the references can 
be matched to Dimensions records (79,669 out of 84,964 papers, or 93.8% of the scientific 
references). For each paper we obtain information on its title, author list, affiliation(s), publishing 
venue, publication date, fields of study, references and citations received. Among the papers we 
analyzed, 79 of the 79,669 are matched to more than one record in Dimensions; hence to avoid 
duplications we keep the single item with most complete records, as determined by the number of 
references and citations.  
 
We also constructed another set of COVID-19 related scientific publications by searching for 
papers published in 2020 with the following query suggested by Dimensions [5]: 
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"2019-nCoV" OR "COVID-19" OR “SARS-CoV-2” OR "HCoV-2019" OR "hcov" OR "NCOVID-
19" OR "severe acute respiratory syndrome coronavirus 2" OR "severe acute respiratory 
syndrome corona virus 2" OR (("coronavirus" OR "corona virus") AND (Wuhan OR China OR 
novel)), 
 
yielding in total 40,733 papers published in 2020 out of all articles indexed by Dimensions.  
S1.3 COVID-19 case and death tracking data 
We use country-level daily statistics for COVID-19 confirmed cases and deaths from two 
independent sources. Our primary data source is the COVID-19 Data Repository provided by the 
Center for Systems Science and Engineering (CSSE) at Johns Hopkins University [6], which has 
been extensively used in COVID-19 related studies. To ensure the robustness of our results, we 
also repeated our analyses using an alternative dataset provided by the European Centre for Disease 
Prevention and Control (ECDC) [7], which includes not only information on COVID-19 confirmed 
cases and deaths, but also country-level covariates such as GDP per capita and population (see 
also S2.3). In our robustness checks (S3.4), we repeated our analyses using the COVID-19 
confirmed deaths reported by ECDC, confirming that our results are not sensitive to the specific 
COVID-19 tracking data source. 
S1.4 Data limitations 
Although our datasets represent among the largest collection of records in their respective domains, 
there are potential limitations of the data readers should keep in mind.  
 
The Overton database assembles documents from a large number of sources, hence there might be 
potential sampling biases across different document types, countries and languages. For example, 
some countries may have more policy documents recorded in the data simply because their policy 
sources are more easily accessible, and documents better organized. Given the novelty of this 
database, we are not aware of other peer datasets that may help us assess the extent of potential 
sampling biases. Therefore, in our analyses, key results are based on comparisons between 
COVID-19 documents and all other documents recorded for that country or organization, i.e. the 
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share of policy attention to COVID-19, which normalizes the total number of policy documents 
published by an entity.  
 
Furthermore, COVID-19 related policy documents are identified through keyword searches, which 
may introduce both false positives and false negatives. Indeed, there have been several other 
notable coronavirus outbreaks in the past, such as SARS in 2003, indicating that our keyword 
search will also yield policy documents about other coronaviruses than COVID-19 (false positives). 
Yet, since our analysis only focuses on policy documents published in 2020, and all other 
coronavirus outbreaks took place before 2020, it suggests that the policy attention on coronavirus 
captured by our 2020 sample primarily concerns COVID-19. Second, false negatives (i.e., 
COVID-19 policy documents that are not captured by the keywords listed above) may also emerge 
from the keyword-based search approaches. Inspecting the official approach used by Overton for 
producing their own COVID-19 analysis [8] reveals that the keyword list contains several COVID-
19 related words not only in English but also some Non-Latin languages (translations based on 
Wikidata [9]). Although this list is still not exhaustive, such efforts may help to reduce potential 
language biases.  
 
Taken together, there are several potential sampling biases by countries and languages that readers 
should keep in mind. However, in the context of regression relationships (e.g., as in Fig. 4 of the 
main text), it is worth noting that noise in explanatory variable (e.g., the COVID-19 policy share) 
will attenuate the results toward zero, making it harder to find a significant statistical relationship.  
Indeed, as measurement errors are likely to introduce noise to our data, they suggest conservative 
biases to the regression relationships we observed. Related, in several different robustness checks, 
we find that if we focus on the portion of the data that has a higher reliability, the relationships we 
observe tend to strengthen further. For example, S3.7 presents robustness checks by separating 
English and non-English speaking countries, showing that if we only focus on English speaking 
countries (less bias by language), the correlations we observe become stronger. Similar trends are 
found in S3.8, where we limit the minimum number of COVID-19 policy documents published by 
each country, which again increases the overall correlation.  
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S2 Methods 
S2.1 Field and topic classifications 
We leverage field and topic classifications from Overton and Dimensions to determine the primary 
focus of each policy document and scientific paper. 
 
Overton uses machine learning approaches to assign fields and topics to policy documents. The 
Overton policy field classification is primarily based on the International Press 
Telecommunications Council (IPTC) Subject Codes taxonomy, the global standards body of the 
news media. In our analysis, we use 18 top-level fields in Overton and further group them into 
three major field categories:  
 
Science & Health: "health", "science and technology". 
Economy & Labour: "economy, business and finance", "labour", "prices". 
Society & Others: "arts, culture and entertainment", "conflicts, war and peace", "crime, law and 
justice", "disaster, accident and emergency incident", "education", "environment", "human 
interest", "lifestyle and leisure", "politics", "religion and belief", "society", "sport", "weather".  
 
The Overton policy topic also implements a more fine-grained classification system. For example, 
in Fig. 1e, we used this classification scheme and show the top 10 topics by volume, after excluding 
one generic topic (“coronavirus disease 2019”). 
 
Dimensions implements the Fields of Research (FOR) classification for scientific papers. The FOR 
is a component of the Australian and New Zealand Standard Research Classification (ANZSRC) 
system, which follows a three-level hierarchy (divisions, groups and fields) and covers a broad set 
of research fields from the sciences and engineering, social sciences, and arts and humanities.  In 
our analysis, we use 22 top-level divisions as the research fields of scientific papers. Analogously, 
as we do for policy documents, we further group 22 top-level divisions into the same three major 
field categories: 
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Science & Health: "Agricultural and Veterinary Sciences", "Biological Sciences", "Chemical 
Sciences", "Earth Sciences", "Engineering", "Environmental Sciences", "Information and 
Computing Sciences", "Mathematical Sciences", "Medical and Health Sciences", "Physical 
Sciences", "Psychology and Cognitive Sciences", "Technology”. 
Economy & Labour: "Commerce, Management, Tourism and Services", "Economics". 
Society & Others: "Built Environment and Design", "Education", "History and Archaeology", 
"Language, Communication and Culture", "Law and Legal Studies", "Philosophy and Religious 
Studies", "Studies in Creative Arts and Writing", "Studies in Human Society".  
S2.2 Policy citation network 
We construct a citation network using all COVID-19 related policy documents, where each 
directed link A→B corresponds to a citation from document A to document B. Self-citations (self-
loops) are removed and only nodes with non-zero degree (i.e. documents that either cite or are 
cited by at least one other COVID-19 policy document)  are visualized in the network (Fig. 3 of 
the main text). 
 
To compare the importance of documents from various institutions, we simulate a random node 
removal procedure and study the relative size of the giant weakly connected component when a 
small fraction f of the nodes is removed [10, 11]. For each institution type (IGO/think 
tank/government), we perform 50 independent simulations. 
 
The relative importance of individual nodes is measured by k-core decomposition [12, 13], where 
k-core is defined as the maximal subgraph with all nodes having degree no smaller than k. A node 
has coreness of k if it belongs to k-core but not (k+1)-core. Nodes with higher/lower coreness are 
located in the core/periphery of the network. We treat the network as undirected (defining degree 
as the sum of in-degree and out-degree) when calculating the coreness index.  
S2.3 Country-level policy response  
We quantify the COVID-19 policy attention at the individual country level and explore its 
correlation with the country’s effectiveness in containing the pandemic. For each country in our 
analysis, we mark the calendar date on which three deaths from COVID-19 in one day were first 
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recorded [14]. We then calculate the share of COVID-19 policy documents among all policy 
documents in a country during the prior 30 days (i.e., in the 30 days before three daily deaths were 
first recorded in that country), which approximates the country’s COVID-19 policy attention. We 
further measure the country’s total deaths from COVID-19 over the following 30 days (i.e., in the 
30 days after three daily deaths were first recorded in that country), which approximates the 
country’s effectiveness in containing the pandemic. Both calculations are only possible if a country 
(1) has three daily deaths between January 31 and April 26, 2020; and (2) has at least one policy 
document published in the prior 30 days. After this filtering, there are 59 countries left, which we 
use as the full sample for Fig. 4 of the main text and for the various regression analyses (S2.4). 
This subset accounts for approximately 92.3% of confirmed deaths worldwide as of May 30th. 
 
In addition to the share of COVID-19 policy documents, we consider an orthogonal COVID-19 
policy attention measure, the stringency index, provided by the Oxford COVID-19 Government 
Response Tracker (OxCGRT) [15, 16]. Independent of the Overton policy document database that 
we rely on, OxCGRT collects information on 17 indicators of government responses to the 
COVID-19 pandemic such as travel restrictions and school closures. All these indicators are 
aggregated into an overall government response index (the stringency index), which records how 
the response of governments has varied over all indicators. The value of the stringency index is 
from 0 to 100 (from low to high level of government action). As of May 31, 2020, OxCGRT 
provides the daily stringency index for more than 160 countries. Consistent with our analysis in 
Fig. 4 of the main text, for each country we calculate an average stringency index during the prior 
30 days (i.e., in the 30 days before three daily deaths were first recorded in that country), which 
serves as a separate proxy for a country’s COVID-19 policy attention. The average stringency 
index is available for all the 59 countries that we analyze. We find that, although the stringency 
index measures policies that are specifically designed toward containing the pandemic, it exhibits 
a comparable level of predictive power as our measure (S3.10), which as an orthogonal source of 
policy data further confirms the robustness of our findings. 
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S2.4 Regression methods 
We employ an ordinary least squares (OLS) regression model to estimate the relations between 
the country-level COVID-19 policy attention and the country’s effectiveness in containing the 
pandemic. The OLS regression takes the following form: !! = #" + ##%!,# + #%%!,% + #&%!,& + #'%!,' + #(%!,( + &!,                         (Eq. 1) 
where ' indexes a country and &! is the error term. Other variables are defined as follows: 
 
Dependent variable: The dependent variable !! = log#" +,-.ℎ! is the total COVID-19 confirmed 
deaths in the logarithmic scale in country '  in the 30 days after three daily deaths were first 
recorded in that country (i.e., the following 30 days), which approximates the country’s 
effectiveness in containing the pandemic. 
 
Independent variable of interest: The variable %!,#	is the share of COVID-19 policy documents 
among all policy documents published by country ' in the 30 days before three daily deaths were 
first recorded (i.e., the prior 30 days) in that country. In our analysis, we use three different 
variations for the independent variable %!,#: 
1) %!,# = #2345+!/#788! is the ratio between the number of COVID-19 policy documents 
(#2345+!) and the number of all policy documents (#788!) published by country ' in the 
prior 30 days. Note that, to include country ' in the regression model, the country must 
have published at least one policy documents (#788! >= 0) in the prior 30 days and cover 
the entire following 30 days (see S2.3 for details). 
2) %!,# =	log#"(#2345+!/#788!)	 is the share of COVID-19 policy documents, now 
measured on the logarithmic scale. Note that the logarithmic value is undefined when #2345+! = 0 . The regression thus drops countries where the logarithmic value is 
undefined and only includes countries that published at least one COVID-19 policy 
document (i.e., #2345+! >= 1) in the prior 30 days. Alternatively, we consider this 
logarithmic regression model but with a dummy variable for country cases where #2345+! = 0. In this case, we continue to include all countries by resetting the logarithmic 
COVID share value to 0 and using the dummy variable to account for these otherwise 
dropped cases (see S3.4 for details). 
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3) %!,# =	log#"[(#2345+! + 1)/(#788! + 1)]	 is the COVID share in the logarithmic scale. 
As in 1), we add one to both the number of COVID-19 policy documents and the number 
of all policy documents before taking the log. This provides a simple alternative to avoid 
dropping cases where #2345+! = 0 and is visualized in Fig. 4 of the main text. 
 
Dummy variable: The dummy variable %!,% = +!)*+,- indicates whether country ' has published 
COVID-19 policy documents in the prior 30 days. The value +!)*+,-= 1 if the number of COVID-
19 policy documents published by country ' is 0 (i.e., #2345+! = 0) in the prior 30 days, and +!)*+,- = 0 if otherwise (i.e., #2345+! >= 1 ). When including the COVID share %!,# =	log#"(#2345+!/#788!)	  together with the dummy variable %!,% = +!)*+,-  in the regression 
model, the dummy variable %!,%  accounts for the effects of publishing no COVID-19 policy 
documents in the prior 30 days on the total deaths in the following 30 days. 
 
Other control variables: In the regression model, we additionally control for three variables that 
may also have effects on a country’s measured response. (1) %!,& =	log#" (@+ABC!) is the GDP 
per capita of country ' in the logarithmic scale. (2) %!,' = 	log#"(ADB!) is the total population of 
country ' in the logarithmic scale. (3) %!,( = +-!!  is the calendar day of 2020 on which three 
confirmed deaths from COVID-19 in one day were first recorded in country '. 
S3 Robustness checks 
S3.1 Temporal correlation between COVID-19 policy attention and the evolution of the 
pandemic  
We compare the share of COVID-19 policy attention and total confirmed deaths from COVID-19 
over time, finding a high degree of similarity between the two trajectories (Fig. S2A). To test if 
there are systematic delays between the share of COVID-19 policy attention and the pandemic 
progress (both cases and deaths), we further calculate the correlation between the two time-series. 
To account for the approximate exponential growth of both curves, we take the first-order 
difference of logarithm transformation, defined as E.	 =	log#" F.0# − 	log#"F.. 
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Correlations between the transformed series suggest that the relationship between the time series 
is closest when the time offset, Δt, between the share of COVID-19 policy documents and COVID-
19 deaths is close to 0 (see Fig. S2B for deaths and Fig. S2C for cases), suggesting a high degree 
of synchronicity between the share of COVID-19 policy attention and how the pandemic evolves. 
S3.2 Evolution of fields and topics of policy documents and cited papers 
In Fig. 1D of the main text, we group COVID-19 related policy documents into three major field 
categories (see also S2.1) and observe clear shifts in policy attention related to the pandemic, with 
policy priorities shifting from issues in public health to economy and society. At the narrower topic 
level, in Fig. 1e and 1f we find a clear decrease in the share of health-related topics and an increase 
of topics related to economy and society since early March 2020.  
 
Here, we test the robustness of these observations by looking into data by month and for individual 
fields. We find similar shifts in topics of COVID-19 policy documents around March 2020 (Fig. 
S3A), with January and February primarily focusing on public health and medicine while April 
and May showing more expansive subject orientations and increased focus on social and economic 
issues.  Further, we calculate the share of COVID-19 policy documents by each field and plot the 
results for the top 10 fields ranked by total COVID-19 policy documents (Fig. S3B), finding 
similar shifts in COVID-19 policy attention from health to economy and society. Similarly, we 
further consider the share of scientific papers cited by COVID-19 policy documents for individual 
Fields of Research (FOR). We find a clear shift of COVID-19 policy documents from drawing 
primarily upon biomedical literature to citing economics, society, and other FOR (see Fig. S3C for 
the top 10 FOR), showing the robustness of our results reported in Fig. 2C of the main text. 
 
Furthermore, we repeat our analyses on the evolution of fields for other (i.e., non-COVID-19) 
policy documents published in the same period. We find that the shares of policy documents by 
three major field categories (Fig. S4A) and individual fields (Fig. S4B) stay relatively stable over 
time, suggesting that the shifts are observed in COVID-19 policy documents only.  
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S3.3 Robustness checks on the use of science and policy document impact 
Figure 2F of the main text documents a positive relationship between the use of scientific 
references and the number of citations from other COVID-19 policy documents, with policies that 
reference science receiving 0.436 additional policy citations on average (more than doubling the 
baseline rate). Here we further test the robustness of this result in a linear regression model to 
control for the publication date of the document as well as fixed effects for the country and type 
of institution, finding that all else being equal, COVID-19 policy documents that cite scientific 
papers are associated with 0.322 more policy citations than those that do not (P < 0.001). We also 
separate citations they receive into citations from the same institution or different policy 
institutions, finding additional citations for both types (0.184 more policy citations from the same 
institution and 0.137 more policy citations from the other institutions). 
 
Table S1. Regressions considering the effects of policy publication date, the country, and the type 
of the institution. 
 
Notes: Column (4) and (5) shows the results on using citations from same/different sources only. Standard errors in 
parentheses. Significant level: *p<0.1; **p<0.05; ***p<0.01. 
S3.4 Robustness checks on the relations between the share of policy attention and a country’s 
effectiveness in response 
We explore the relationship between a country’s COVID-19 policy response and its effectiveness 
in containing the pandemic by employing the ordinary least squares (OLS) regression model given 
in Eq. (1), as described in S2.4. The dependent variable	log#"	(+,-.ℎ) is the logarithmic count of 
the country’s total deaths from COVID-19 in the 30 days after 3 daily deaths were first recorded 
in that country. The independent variable of interest is the share of COVID-19 policy attention 
same institution different institution
(1) (2) (3) (4) (5)
0.436*** 0.516*** 0.322*** 0.184*** 0.137***
(0.053) (0.052) (0.054) (0.040) (0.023)
-0.010*** -0.011*** -0.007*** -0.004***
(0.001) (0.001) (0.001) (0.000)
Institution type Yes Yes Yes
Institution country Yes Yes Yes
0.297*** 1.302*** 1.097* 0.732* 0.365
(0.240) (0.078) 0.585 (0.431) (0.250)
Observations 7730 7730 7730 7730 7730
Adj. R2 0.009 0.031 0.065 0.045 0.055
RMSE 1.877 1.855 1.823 1.344 0.779
F  statistic 68.84 125.61 9.48 6.83 8.09
Constant
Dependent variable: Policy citations
totalVariables
D_cites_science
Policy date
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given by three alternative functional forms, namely, the linear share of COVID-19 policy 
documents, #2345+/#788; the logarithmic share of COVID policy documents,	log#"	(#)*+,-#233 ); 
and the logarithmic COVID share after adding 1 for both numbers of COVID and all policy 
documents: 	log#"	(#)*+,-0##2330# )  (see S2.4 for more detail). Here, together with each of these 
functional forms for the independent variable of interest, we gradually include other control 
variables in the regression. 
 
Table S2. Regressions considering the effects of COVID-19 policy attention on total deaths. 
 
Notes: The dummy variable !	"#$%&= 1 if ##$%&! = 0, and !	"#$%&= 0 if otherwise. Countries where##$%&! = 0 
are dropped in column (4), and these countries are included in column (5) after resetting the value of 	log'((##$%&!/#/00) to 0. Standard errors in parentheses. Significant level: *p<0.1; **p<0.05; ***p<0.01. 
 
In columns (1-3) of Table S2, we use the COVID share #2345+/#788 as a proxy for the share 
of COVID-19 policy attention. We find that this COVID-19 policy attention share by itself exhibits 
a significant, negative correlation with total deaths (see column (1)). Further, in column (2) we 
include the dummy variable +)*+,- that indicates whether a country has yet published COVID-
19 policy documents and find the negative correlation further improves. In column (3) we include 
three other control variables, namely, GDP per capita, population, and the calendar day of 3 daily 
deaths were first recorded for each country. We find that the COVID share still has a significant 
predictive power for the total deaths after controlling for all other variables.  
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In columns (4-5), we use the COVID share in the logarithmic scale 	log#"(#)*+,-#233 ) as a proxy for 
the share of COVID policy attention. When including 	log#"(#)*+,-#233 ) solely in column (4), the 
regression drops countries with #2345+ = 0  (i.e., where 		log#"(#)*+,-#233 )  is undefined). In 
columns (5-6), we include all countries after resetting	log#" H#)*+,-#233 I = 0 for countries where #2345+ = 0 and use the dummy variable +	)*+,- to account for publishing no COVID-19 policy 
documents. We find that the negative correlation between the COVID share and total deaths 
remain strong and significant.  
 
In columns (7-9), we repeat the regression by using 	log#"(#)*+,-0##2330# ) as a proxy for the share of 
COVID policy attention. We find that the negative correlations remain robust, with a 10 percent 
increase in the adjusted COVID-19 policy share variable predicting 3.19 percent fewer deaths. 
GDP per capita has no significant effect on total deaths, whereas population size has a positive 
effect. Moreover, the calendar day of the first 3 daily deaths has significantly negative effects, 
suggesting that a later onset of COVID-19 outbreak is associated with fewer deaths in the 
following 30 days. These variables together can explain up to 55.4% of the variation in total deaths. 
S3.5 Thresholds on the minimum number of policy documents 
We further check the robustness of the negative correlation between the COVID-19 policy 
attention in the prior 30 days and the total deaths in the following 30 days (i.e., the 30 days after 3 
daily deaths were first recorded), by restricting the analysis to a minimum threshold number of 
policy documents that a country published in the prior 30 days (i.e., the 30 days before 3 daily 
deaths were first recorded),  
 
Table S3 summarizes the results of regressions where we only include countries that published at 
least 10 policy documents in the prior 30 days. We find that the negative correlations remain 
largely significant. In particular, we notice from column (9) that the regression coefficient of the 
COVID share increases to -0.375 (from -0.319 in Table S2), suggesting that that COVID share 
exhibits a slightly stronger predictive power for total deaths in countries that published more policy 
documents. 
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Table S3. Regressions considering the effects of COVID-19 policy attention on total deaths for 
countries that published at least 10 policy documents in the prior 30 days. 
 
Notes: The dummy variable !	"#$%&= 1 if ##$%&! = 0, and !	"#$%&= 0 if otherwise. Countries where##$%&! = 0 
are dropped in column (4), and these countries are included in column (5) after resetting the value of 	log'((##$%&!/#/00) to 0. Standard errors in parentheses. Significant level: *p<0.1; **p<0.05; ***p<0.01. 
 
In Table S4, we further limit our regression analysis to countries that published at least 25 policy 
documents in the prior 30 days. We notice that the regression coefficient of COVID share in 
column (9) further increases to -0.467, showing that the share of COVID-19 policy attention in the 
prior 30 days in countries that published more policy documents has again a steeper relationship 
with the total deaths in the following 30 days. With the smaller number of country observations 
that result from these policy document count restrictions, the standard errors tend naturally to 
increase in these regressions, yet most specifications remain statistically significant.  Overall, these 
analyses tend to further support the robustness of our findings.    
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Table S4. Regressions considering the effects of COVID policy attention on total deaths for 
countries that published at least 25 policy documents in the prior 30 days. 
 
Notes: The dummy variable !	"#$%&= 1 if ##$%&! = 0, and !	"#$%&= 0 if otherwise. Countries where##$%&! = 0 
are dropped in column (4), and these countries are included in column (5) after resetting the value of 	log'((##$%&!/#/00) to 0. Standard errors in parentheses. Significant level: *p<0.1; **p<0.05; ***p<0.01. 
S3.6 Alternative measures for effectiveness in response and other data sources 
In Fig. 4A of the main text, we presented the negative correlation between the share of COVID-
19 policy attention in the prior 30 days and the total confirmed deaths in the following 30 days, 
where we use the COVID-19 death tracking data provided by Johns Hopkins University (JHU). 
Here, we consider alternative measures and show that our results are robust when using total 
confirmed cases (Fig. S5A; columns (1-2) of Table S5) and confirmed deaths per million 
population of a country (Fig. S5B; columns (3-4) of Table S5) in the following 30 days. 
 
We further leverage a new dataset for daily COVID-19 case and death statistics, provided by the 
European Centre for Disease Prevention and Control (ECDC). Country-level death statistics 
collected by JHU and ECDC are highly correlated with each other. For example, the Pearson 
correlation coefficient between the total deaths (in the logarithmic scale) in the following 30 days 
recorded by the two data sources is 0.996. Here, we show that our results remain robust when using 
ECDC death statistics (Fig. S5D; columns (5-6) of Table S5). 
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Table S5. Regressions considering the effects of COVID policy attention on the effectiveness in 
containing the pandemic.  
 
Notes: The dummy variable !	"#$%&= 1 if ##$%&! = 0, and !	"#$%&= 0 if otherwise. Standard errors in parentheses. 
Significant level: *p<0.1; **p<0.05; ***p<0.01. 
S3.7 Results for English-speaking countries 
To address possible concerns on the potential bias by language in Overton policy documents, we 
further performed robustness checks by separating English and non-English speaking countries in 
our analysis. Based on whether English is an official language [17], we consider a combination of 
three sets of countries as English-speaking countries in our analysis: (1) Countries where English 
is a de facto (i.e., practices that exist in reality) official language; (2) Countries where English is a 
de jure (i.e., practices that are legally recognized) and de facto official language; (3) Countries 
where English is a de facto official, but not primary language.  
 
Out of all 59 countries in our analysis for Fig. 4A of the main text, 14 countries are English 
speaking countries. If we only focus on English speaking countries, the Pearson correlation 
between the share of COVID-19 policy attention in the prior 30 days and the total deaths in the 
following 30 days increases from -0.551 (Fig. 4A of the main text) to -0.659 (Fig. S5C; columns 
(7-8) of Table S5), showing that the correlation becomes stronger and remains significant (P = 
0.01) without other controls, and despite the small sample size, suggesting the robustness of the 
results.  
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S3.8 Thresholds on the minimal number of COVID-19 policy documents 
We further focus on the portion of the data that has a higher reliability in our analysis by limiting 
countries that have published a minimum threshold number of COVID-19 policy documents in the 
prior 30 days. We find that the negative correlation between the share of COVID-19 policy 
attention and total deaths that we observe tends to strengthen. Specifically, when increasing the 
minimum number of COVID-19 policy documents from 1 to 10, the Pearson correlation 
coefficient increases from -0.63 to -0.78 (Fig. S6), and the correlation remains largely significant 
when controlling for other variables (Table S6).  
 
Table S6. Regressions considering the effects of COVID policy attention on total deaths for 
countries that published a minimum number of COVID policy documents in the prior 30 days. 
 
Notes: Standard errors in parentheses. Significant level: *p<0.1; **p<0.05; ***p<0.01. 
S3.9 Robustness checks on the onset of outbreaks 
As a reference point approximating the onset of the outbreak, the paper takes the day where 3 daily 
deaths were first recorded. Here we present robustness checks on this reference point (Fig. S7; 
Table S7). Specifically, when taking the day where the first death was recorded in each country as 
the reference point [15, 16], a total of 82 countries are included in the analysis, and we find a 
significantly negative correlation (-0.550) between COVID share and total deaths (Fig. S7A; 
columns (1-2) of Table S7). Taking the reference point as the day when 5 daily deaths were first 
recorded (Fig. S7B; columns (3-4) of Table S7) and the day where 10 daily deaths were first 
recorded (Fig. S7C; columns (5-6) of Table S7), the negative correlation between COVID share 
and total deaths remains strong and significant, again confirming the robustness of our results.  
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Table S7. Regressions considering the effects of COVID policy attention on total deaths in the 
prior 30 days under different reference points. 
 
Notes: The dummy variable !	"#$%&= 1 if ##$%&! = 0, and !	"#$%&= 0 if otherwise. !23 is the calendar day of the 
reference point in 2020. Standard errors in parentheses. Significant level: *p<0.1; **p<0.05; ***p<0.01. 
 
Besides the number of daily deaths, we use an alternative method by taking the day where a 
cumulative number of 100 deaths was first recorded as the reference point. After checking the 
relations between the share of COVID-19 policy documents in the 30 days before total 100 deaths 
was first recorded in a country and the total deaths after total 100 deaths was first recorded in that 
country, we find that the negative correlation further improves and remains significant (Fig. S7D; 
columns (7-8) of Table S7). Overall, these results support the robustness of our results. 
S3.10 Comparison with the Stringency Index 
Finally, we leverage an independent measure on COVID-19 policy, the stringency index provided 
by the Oxford COVID-19 Government Response Tracker (OxCGRT) [15, 16], to further test the 
robustness of our finding on the relationship between COVID-19 policy attention and the 
effectiveness in containing the pandemic. For each country we calculate an average stringency 
index during the prior 30 days and employ it to predict the total deaths in the following 30 days. 
Table S8 summaries the results of regressions that include both the share of COVID-19 policy 
documents and the average stringency index together with other control variables. In order to 
compare the values of regression coefficients, here we take the z-score for all variables. 
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Table S8. Regressions considering the effects of both the share of COVID-19 policy documents 
and the average stringency index on total deaths. 
 
Notes: The dummy variable !"#$%&= 1 if ##$%&! = 0, and !"#$%&= 0 if otherwise. Countries where ##$%&! = 0 
are dropped in columns (1) and (4), and these countries are included in other columns after resetting the value of 	log'((##$%&!/#/00) to 0. Standard errors in parentheses. Significant level: *p<0.1; **p<0.05; ***p<0.01. 
 
In columns (1-3) of Table S8, we include alternative functional forms for the share of COVID-19 
policy documents and the average stringency index, finding that the COVID share and the 
stringency index have independent and comparable predictive power for total deaths. In columns 
(4-5), we include both the policy document share and the stringency index and find that they 
augment each other’s predictive power and have similar coefficient magnitudes.  In columns (6-
10), we include the dummy variable whose value +)*+,-= 1 if a country did not publish any 
COVID-19 policy documents in the prior 30 days and +)*+,-= 0 if otherwise. We find that the 
predictive powers of COVID share and stringency index are again similar to each other and 
augmentative. 
 
In columns (11-15), we further include controls for GDP per capita, population, and the calendar 
day where 3 daily deaths were first recorded in each country. After controlling for all variables, 
we find that the effects of the share of COVID-19 policy documents remain negative and 
significant in columns (11-12). Moreover, the COVID share exhibits a slightly stronger power than 
the stringency index in predicting total deaths in columns (14-15). These observations are 
encouraging, as the stringency index measures policies that are specifically designed toward 
containing the pandemic, which exhibits a comparable level of predictive power as our measure. 
Overall these results further confirm the robustness of our results, showing that at the country level, 
greater COVID-19 policy attention predicts fewer subsequent deaths.   
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SI Figures 
 
Fig. S1 World map of policy data coverage. (A) Number of policy documents published in 2020 
in our data. (B) Number of COVID-19 policy documents in our regression analysis, where we 
restrict that a country has 3 daily deaths between January 31 and April 26, 2020; and has at least 
one policy document published in the 30 days before 3 daily deaths were first recorded. We 
visualize (#docs+1) for the logarithmic color scale. 
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Figure S2. Share of COVID-19 policy docs and the pandemic response. (A) Trajectories of the 
global share of COVID-19 policy documents among all policy documents and the number of total 
confirmed deaths. (B) Pearson correlation between the shifted COVID-19 share curve and the total 
cases curve. (C) Pearson correlation between the shifted COVID-19 share curve and the total 
deaths curve. The offset is positive when shifting the COVID-19 share curve forward. 
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Figure S3. Field evolution of COVID-19 policy documents and their cited papers. (A) Word 
cloud of topics of COVID-19 policy documents published in each month of 2020. The size of a 
topic corresponds to the share of the topic among all topics in the documents. (B) The share of 
total COVID-19 policy documents across time by fields (21-day moving average). (C) Field share 
of total COVID policy cited papers across time by research fields (21-day moving average). Only 
the top 10 fields are presented. 
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Figure S4. Topic and field shifts of all other policy docs. (A) The share of total non-COVID-19 
policy documents across time by three field categories (21-day moving average). (B) The share of 
total non-COVID-19 policy documents across time by fields (21-day moving average). Only the 
top 10 fields are presented. 
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Figure S5. The negative correlations between the share of COVID-19 policy attention and 
alternative measures of pandemic situation. (A) The total confirmed cases recorded by Johns 
Hopkins University (JHU). (B) The deaths per 1 million population of a country recorded by JHU. 
(C) Results on total confirmed deaths recorded by JHU for countries where English is an official 
language. (D) The total confirmed deaths recorded by European Centre for Disease Prevention and 
Control (ECDC).  
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Figure S6. Thresholds of the minimum number of COVID-19 policy documents. The 
minimum number of COVID-19 policy documents is increased from 1 in panel (A) to 10 in panel 
(F), as indicated in each panel. The negative correlation between COVID-19 policy attention and 
the pandemic situation tends to become steeper as the minimum number of COVID-19 policy 
documents increases.  
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Figure S7. Reference point timing for COVID-19 situation within each country. (A) 
Reference point where the first death was recorded in each country. (B) Reference point where 5 
deaths in a day were first recorded in each country. (C) Reference point where 10 deaths in a day 
were first recorded in each country. (D) Reference point where a total number of 100 deaths were 
first recorded in each country. 
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